Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06521255
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-15
Brief Title:
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With RelapsedRefractory Diffuse Large B-Cell Lymphoma
Sponsor:
Organization:
None